Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Oct 19;3(1):30-32.
doi: 10.1016/j.hrcr.2016.08.004. eCollection 2017 Jan.

Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only?

Mauro Biffi  1 , Giulia Massaro  1 , Igor Diemberger  1 , Cristian Martignani  1 , Alessandro Corzani  1 , Matteo Ziacchi  1
Affiliations
Case Reports

Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only?

Mauro Biffi et al. HeartRhythm Case Rep. .
No abstract available

Keywords: Cardiac resynchronization therapy; Heart failure; Persistent left superior vena cava; Reverse remodeling; VDD mode.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Specific characteristics of the Protego DF-1 Pro MRI S DX lead.
Figure 2
Figure 2
A: Venogram taken from the persistent left superior vena cava showing a posterior coronary vein suitable for left ventricle (LV) lead placement. Note the high-lateral right atrial placement of the atrial sensing dipole. B: Selective venogram from the posterior vein. C: Right anterior oblique view of the active fixation lead placed in the posterior coronary vein chosen as target. D: Left anterior oblique view of the active fixation LV lead placed inside the target coronary vein.
Figure 3
Figure 3
Long-term electrical performance of both leads at 4 months follow-up.
See this image and copyright information in PMC

References

    1. Biffi M., Boriani G., Frabetti L., Bronzetti G., Branzi A. Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. Chest. 2001;120:139. - PubMed
    1. Sticherling C., Zabel M., Spencker S., Meyerfeldt U., Eckardt L., Behrens S., Niehaus M., ADRIA Investigators Comparison of a novel, single-lead atrial sensing system with a dual-chamber implantable cardioverter- defibrillator system in patients without antibradycardia pacing indications results of a randomized study. Circ Arrhythm Electrophysiol. 2011;4:56–63. - PubMed
    1. Brignole M., Auricchio A., Baron-Esquivias G. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) Eur Heart J. 2013;34:2281–2329. - PubMed
    1. D’Onofrio A., Botto G., Mantica M. Incremental value of larger interventricular conduction time in improving cardiac resynchronization therapy outcome in patients with different QRS duration. J Cardiovasc Electrophysiol. 2014;25:500–506. - PubMed
    1. Biffi M., Bertini M., Ziacchi M., Diemberger I., Martignani C., Boriani G. Left ventricular lead stabilization to retain cardiac resynchronization therapy at long term: when is it advisable? Europace. 2014;16:533–540. - PubMed

Publication types

LinkOut - more resources